Back to results
US 2023/0057232 A1Published application
Isotopically labeled bile acid derivatives
AssigneeIntercept Pharmaceuticals, Inc.
InventorsGabriel GALVIN, Kevin SCHAAB, Matthew YANIK
Life of this patent
Estimating the term…
Abstract
The present application relates to isotopically labeled compounds of Formula I and methods of preparation and use thereof
Claims12
A compound of Formula I
- or a pharmaceutically acceptable salt thereof, wherein
- R1 is OH, O-glucuronide, OSO3H, SO3H, CO2R5, 14CO2R5, C(O)R6, 14C(O)R6;
- R2 is H, D, or OH;
- R3 is OH or O-glucuronide;
- R4 is OH or O-glucuronide;
- R5 is H or substituted or unsubstituted alkyl;
- R6 is NH(CH2)2SO3H, NHCH2CO2H, or N(CH3)CH2CO2H or glucuronic acid moieties,
- wherein hydrogens in can be replaced with deuterium;
- R11 is Z11b, hydroxy, halogen, alkoxy, or oxo when Z11a is not present;
- R16 is Z16a, hydroxy, halogen, alkoxy, or oxo when Z16b is not present;
- R23 is Z23a or alkyl;
- and
- Z1a, Z1b, Z2a, Z2b, Z3, Z4a, Z4b, Z5, Z6, Z7, Z8, Z9, Z11a, Z11b, Z12, Z14, Z15a, Z15b, Z16a, Z16b, Z17, Z18, Z19, Z20, Z21, Z22a, Z22b, Z23a, Z23b, Z24a, Z24b, or Z25 is independently selected from H (hydrogen) or D (deuterium), and at least one of Z1a, Z1b, Z2a, Z2b, Z3, Z4a, Z4b, Z5, Z6, Z7, Z8, Z9, Z11a, Z11b, Z12, Z14, Z15a, Z15b, Z16a, Z16b, Z17, Z18, Z19, Z20, Z21, Z22a, Z22b, Z23a, Z23b, Z24a, Z24b, or Z25 is D;
- and
- any carbon atom is 12C, 13C, or 14C.
12 more elements
Dependencies are inferred from the claim text.